jRCT2031220407已完成不适用
KRP-KC121E Phase 2 -A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study in Patients with Meibomian Gland Dysfunction
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Aged over 18 years at the time of Informed Consent(any gender)
- •Live in Japan
- •Have Meibomian Gland Dysfunction in both eyes
- •Meet the other protocol-specified inclusion criteria
排除标准
- •Unable to discontinue wearring contact lens during the study
- •Have history of, or scheduled ocular surgery during the study
- •Have active ocular disease
- •Have severe systemic illness
- •Known history of hypersensitivity to any of the drugs used in the study
- •Patient who is pregnant, lactating, potentially pregnant
- •Have judged that it is inappropriate to participate in this study by investigator
- •Meet the other protocol-specified exclusion criteria
结局指标
主要结局
-
Improvement in inflammation, adverse events etc.
次要结局
未报告次要终点
研究者
相似试验
招募中
1 期
Treatment of patients with leukemia using NK cellsCondition 1: Acute lymphoblastic leukemia (ALL). Condition 2: Chronic lymphocytic leukemia (CLL).Acute lymphoblastic leukaemiaChronic lymphocytic leukaemiaIRCT2017083027520N9Stem Cell And Regenerative Medicine Institute10
未知
3 期
A phase III, double blind, comparative study of KRN125Chemotherapy-induced neutropeniaJPRN-jRCT2080221407Kyowa Hakko Kirin Co., Ltd.
尚未招募
2 期
An Ayurvedic Management Of Senile Immature CataractCTRI/2023/07/055316DR SUPRIYA G
进行中（未招募）
不适用
Safety and Efficacy of Cariprazine as an Adjunctive to AntidepressantTherapy in Major Depressive DisorderMedDRA version: 15.0Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873MedDRA version: 15.0Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873Major Depressive DisorderEUCTR2011-005179-18-SKForest Research Institute, Inc810
进行中（未招募）
1 期
.MedDRA version: 16.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873MedDRA version: 16.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873Major Depressive DisorderEUCTR2011-005179-18-SEForest Research Institute, Inc819